Immunological studies of haemophilic patients with inhibitors treated with Factor VIII concentrates in a protocol to induce immunotolerance.
D005169:Factor VIII / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D006467:Hemophilia A / Q000276:immunology* / Q000628:therapy; D006801:Humans; D007108:Immune Tolerance; D008297:Male; D013601:T-Lymphocytes / Q000145:classification
D005169:Factor VIII